Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1999 Aug;67(2):189–194. doi: 10.1136/jnnp.67.2.189

123I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease

S Orimo 1, E Ozawa 1, S Nakade 1, T Sugimoto 1, H Mizusawa 1
PMCID: PMC1736461  PMID: 10406987

Abstract

OBJECTIVES—123I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy is clinically used to estimate local myocardial sympathetic nerve damage in some forms of heart disease, autonomic nerve disturbance in diabetic neuropathy, and disturbance of the autonomic nervous system in neurodegenerative disease. In the present study, examinations were performed to clarify (1) the proportion of cardiac sympathetic nerve disturbance in Parkinson's disease, (2) the usefulness of 123I-MIBG myocardial scintigraphy to detect sympathetic nerve disturbances compared with autonomic function tests, (3) cardiac function in patients who have a decreased MIBG uptake in 123I-MIBG myocardial scintigraphy, (4) the usefulness of 123I-MIBG myocardial scintigraphy to differentiate Parkinson's disease from the other neurological diseases mimicking it.
METHODS—123I-MIBG myocardial scintigraphy was performed, together with autonomic function tests and cardiac examinations in 46 patients with Parkinson's disease and 25 patients with vascular parkinsonism, essential tremor, or multiple system atrophy.
RESULTS—In an anterior image study, the average count per pixel in heart to mediastinum (H/M) ratio decreased in 80% of the patients with Parkinson's disease in the early phase and 84% in the late phase. The mean H/M ratio in Parkinson's disease was significantly lower than that in controls and the other diseases. The H/M ratio tended to decrease with the disease progression. In almost half of the patients in Hoehn and Yahr stage I, the H/M ratio was already decreased. The sympathetic skin response in upper and lower limbs, head up tilt test, and coefficient of variation of R-R interval were abnormal in 17%, 31%, 30%, and 17% of the patients, respectively. All the patients with abnormal autonomic functions were in Hoehn and Yahr stage III, IV, or V. Echocardiography showed normal left ventricular function. Twenty four hour Holter electrocardiography detected no serious arrhythmias except for one patient with non-sustained ventricular tachycardia.
CONCLUSION—123I-MIBG myocardial scintigraphy might detect early disturbances of the sympathetic nervous system in Parkinson's disease and might give useful diagnostic information to differentiate vascular parkinsonism, essential tremor, and multiple system atrophy from Parkinson's disease.



Full Text

The Full Text of this article is available as a PDF (111.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Braune H. J., Korchounov A. M., Schipper H. I. Autonomic dysfunction in Parkinson's disease assessed by sympathetic skin response: a prospective clinical and neurophysiological trial on 50 patients. Acta Neurol Scand. 1997 May;95(5):293–297. doi: 10.1111/j.1600-0404.1997.tb00213.x. [DOI] [PubMed] [Google Scholar]
  2. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. The Consensus Committee of the American Autonomic Society and the American Academy of Neurology. Neurology. 1996 May;46(5):1470–1470. doi: 10.1212/wnl.46.5.1470. [DOI] [PubMed] [Google Scholar]
  3. Fagret D., Wolf J. E., Vanzetto G., Borrel E. Myocardial uptake of metaiodobenzylguanidine in patients with left ventricular hypertrophy secondary to valvular aortic stenosis. J Nucl Med. 1993 Jan;34(1):57–60. [PubMed] [Google Scholar]
  4. Forno L. S., Norville R. L. Ultrastructure of Lewy bodies in the stellate ganglion. Acta Neuropathol. 1976 Mar 30;34(3):183–197. doi: 10.1007/BF00688674. [DOI] [PubMed] [Google Scholar]
  5. Goldstein D. S., Holmes C., Cannon R. O., 3rd, Eisenhofer G., Kopin I. J. Sympathetic cardioneuropathy in dysautonomias. N Engl J Med. 1997 Mar 6;336(10):696–702. doi: 10.1056/NEJM199703063361004. [DOI] [PubMed] [Google Scholar]
  6. Hakusui S., Yasuda T., Yanagi T., Tohyama J., Hasegawa Y., Koike Y., Hirayama M., Takahashi A. A radiological analysis of heart sympathetic functions with meta-[123I]iodobenzylguanidine in neurological patients with autonomic failure. J Auton Nerv Syst. 1994 Sep;49(1):81–84. doi: 10.1016/0165-1838(94)90023-x. [DOI] [PubMed] [Google Scholar]
  7. Hirashima F., Yokota T., Hayashi M. Sympathetic skin response in Parkinson's disease. Acta Neurol Scand. 1996 Feb-Mar;93(2-3):127–132. doi: 10.1111/j.1600-0404.1996.tb00187.x. [DOI] [PubMed] [Google Scholar]
  8. Hughes A. J., Daniel S. E., Kilford L., Lees A. J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181–184. doi: 10.1136/jnnp.55.3.181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hunter S. The rostral mesencephalon in Parkinson's disease and Alzheimer's disease. Acta Neuropathol. 1985;68(1):53–58. doi: 10.1007/BF00688956. [DOI] [PubMed] [Google Scholar]
  10. Koike Y., Takahashi A. Autonomic dysfunction in Parkinson's disease. Eur Neurol. 1997;38 (Suppl 2):8–12. doi: 10.1159/000113470. [DOI] [PubMed] [Google Scholar]
  11. Kuroiwa Y., Shimada Y., Toyokura Y. Postural hypotension and low R-R interval variability in parkinsonism, spino-cerebellar degeneration, and Shy-Drager syndrome. Neurology. 1983 Apr;33(4):463–467. doi: 10.1212/wnl.33.4.463. [DOI] [PubMed] [Google Scholar]
  12. Langston J. W., Forno L. S. The hypothalamus in Parkinson disease. Ann Neurol. 1978 Feb;3(2):129–133. doi: 10.1002/ana.410030207. [DOI] [PubMed] [Google Scholar]
  13. Magalhães M., Wenning G. K., Daniel S. E., Quinn N. P. Autonomic dysfunction in pathologically confirmed multiple system atrophy and idiopathic Parkinson's disease--a retrospective comparison. Acta Neurol Scand. 1995 Feb;91(2):98–102. doi: 10.1111/j.1600-0404.1995.tb00414.x. [DOI] [PubMed] [Google Scholar]
  14. Merlet P., Valette H., Dubois-Randé J. L., Moyse D., Duboc D., Dove P., Bourguignon M. H., Benvenuti C., Duval A. M., Agostini D. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med. 1992 Apr;33(4):471–477. [PubMed] [Google Scholar]
  15. Minardo J. D., Tuli M. M., Mock B. H., Weiner R. E., Pride H. P., Wellman H. N., Zipes D. P. Scintigraphic and electrophysiological evidence of canine myocardial sympathetic denervation and reinnervation produced by myocardial infarction or phenol application. Circulation. 1988 Oct;78(4):1008–1019. doi: 10.1161/01.cir.78.4.1008. [DOI] [PubMed] [Google Scholar]
  16. Mäntysaari M., Kuikka J., Mustonen J., Tahvanainen K., Vanninen E., Länsimies E., Uusitupa M. Noninvasive detection of cardiac sympathetic nervous dysfunction in diabetic patients using [123I]metaiodobenzylguanidine. Diabetes. 1992 Sep;41(9):1069–1075. doi: 10.2337/diab.41.9.1069. [DOI] [PubMed] [Google Scholar]
  17. Nakajima K., Taki J., Tonami N., Hisada K. Decreased 123I-MIBG uptake and increased clearance in various cardiac diseases. Nucl Med Commun. 1994 May;15(5):317–323. doi: 10.1097/00006231-199405000-00003. [DOI] [PubMed] [Google Scholar]
  18. Ohama E., Ikuta F. Parkinson's disease: distribution of Lewy bodies and monoamine neuron system. Acta Neuropathol. 1976 Apr 26;34(4):311–319. doi: 10.1007/BF00696560. [DOI] [PubMed] [Google Scholar]
  19. Oppenheimer D. R. Lateral horn cells in progressive autonomic failure. J Neurol Sci. 1980 Jun;46(3):393–404. doi: 10.1016/0022-510x(80)90064-7. [DOI] [PubMed] [Google Scholar]
  20. Rabinovitch M. A., Rose C. P., Schwab A. J., Fitchett D. H., Honos G. N., Stewart J. A., Chen L. F., Castilla E. P., Gomez A. A., Abrahamowicz M. A method of dynamic analysis of iodine-123-metaiodobenzylguanidine scintigrams in cardiac mechanical overload hypertrophy and failure. J Nucl Med. 1993 Apr;34(4):589–600. [PubMed] [Google Scholar]
  21. Satoh A., Serita T., Tsujihata M. [Total defect of metaiodobenzylguanidine (MIBG) imaging on heart in Parkinson's disease: assessment of cardiac sympathetic denervation]. Nihon Rinsho. 1997 Jan;55(1):202–206. [PubMed] [Google Scholar]
  22. Schofer J., Spielmann R., Schuchert A., Weber K., Schlüter M. Iodine-123 meta-iodobenzylguanidine scintigraphy: a noninvasive method to demonstrate myocardial adrenergic nervous system disintegrity in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 1988 Nov;12(5):1252–1258. doi: 10.1016/0735-1097(88)92608-3. [DOI] [PubMed] [Google Scholar]
  23. Senard J. M., Valet P., Durrieu G., Berlan M., Tran M. A., Montastruc J. L., Rascol A., Montastruc P. Adrenergic supersensitivity in parkinsonians with orthostatic hypotension. Eur J Clin Invest. 1990 Dec;20(6):613–619. doi: 10.1111/j.1365-2362.1990.tb01909.x. [DOI] [PubMed] [Google Scholar]
  24. Sisson J. C., Shapiro B., Meyers L., Mallette S., Mangner T. J., Wieland D. M., Glowniak J. V., Sherman P., Beierwaltes W. H. Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man. J Nucl Med. 1987 Oct;28(10):1625–1636. [PubMed] [Google Scholar]
  25. Stanton M. S., Tuli M. M., Radtke N. L., Heger J. J., Miles W. M., Mock B. H., Burt R. W., Wellman H. N., Zipes D. P. Regional sympathetic denervation after myocardial infarction in humans detected noninvasively using I-123-metaiodobenzylguanidine. J Am Coll Cardiol. 1989 Nov 15;14(6):1519–1526. doi: 10.1016/0735-1097(89)90391-4. [DOI] [PubMed] [Google Scholar]
  26. Takano H., Yoshimura N. [Markedly decreased cardiac uptake with 123I-MIBG scintigraphy in a case of pure progressive autonomic failure]. Rinsho Shinkeigaku. 1993 Jul;33(7):784–786. [PubMed] [Google Scholar]
  27. Webster D. D. Critical analysis of the disability in Parkinson's disease. Mod Treat. 1968 Mar;5(2):257–282. [PubMed] [Google Scholar]
  28. Wieland D. M., Wu J., Brown L. E., Mangner T. J., Swanson D. P., Beierwaltes W. H. Radiolabeled adrenergi neuron-blocking agents: adrenomedullary imaging with [131I]iodobenzylguanidine. J Nucl Med. 1980 Apr;21(4):349–353. [PubMed] [Google Scholar]
  29. Yokota T., Matsunaga T., Okiyama R., Hirose K., Tanabe H., Furukawa T., Tsukagoshi H. Sympathetic skin response in patients with multiple sclerosis compared with patients with spinal cord transection and normal controls. Brain. 1991 Jun;114(Pt 3):1381–1394. doi: 10.1093/brain/114.3.1381. [DOI] [PubMed] [Google Scholar]
  30. Yoshita M. Differentiation of idiopathic Parkinson's disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 meta-iodobenzylguanidine myocardial scintigraphy. J Neurol Sci. 1998 Feb 18;155(1):60–67. doi: 10.1016/s0022-510x(97)00278-5. [DOI] [PubMed] [Google Scholar]
  31. van Dijk J. G., Haan J., Zwinderman K., Kremer B., van Hilten B. J., Roos R. A. Autonomic nervous system dysfunction in Parkinson's disease: relationships with age, medication, duration, and severity. J Neurol Neurosurg Psychiatry. 1993 Oct;56(10):1090–1095. doi: 10.1136/jnnp.56.10.1090. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES